MWAM
GNOM icon

Manhattan West Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Manhattan West Asset Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,487
Closed -$238K – 143
2025
Q1 		$238K Buy
7,487
+860
+13% +$32.6K 0.06% 127
2024
Q4 		$257K Sell
6,627
-1,026
-13% -$43.1K 0.07% 120
2024
Q3 		$344K Buy
7,653
+998
+15% +$44.6K 0.09% 116
2024
Q2 		$278K Sell
6,655
-142
-2% -$5.93K 0.08% 122
2024
Q1 		$309K Sell
6,797
-2,678
-28% -$122K 0.07% 124
2023
Q4 		$438K Sell
9,475
-20,851
-69% -$850K 0.12% 101
2023
Q3 		$1.11M Buy
30,326
+7,247
+31% +$330K 0.34% 72
2023
Q2 		$1.12M Buy
23,079
+6,985
+43% +$349K 0.42% 69
2023
Q1 		$793K Buy
16,094
+2,420
+18% +$125K 0.35% 76
2022
Q4 		$692K Sell
13,674
-216
-2% -$11.1K 0.35% 74
2022
Q3 		$697K Buy
13,890
+1,189
+9% +$67.1K 0.43% 67
2022
Q2 		$621K Buy
12,701
+2,560
+25% +$130K 0.38% 72
2022
Q1 		$610K Buy
+10,141
New +$640K 0.33% 67

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Manhattan West Asset Management's GNOM Position: Q2 2025 in Review

Manhattan West Asset Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 7,487 shares — an estimated $238K sold.

Manhattan West Asset Management first reported a position in GNOM in Q1 2022 and held it in 13 quarters. The position peaked at $1.12M in Q2 2023. 51 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

  • Manhattan West Asset Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Manhattan West Asset Management sold 7,487 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $238K.
  • Manhattan West Asset Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 13 quarters.
  • Manhattan West Asset Management's Global X Genomics & Biotechnology ETF position peaked at $1.12M in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on Manhattan West Asset Management's 13F filing for Q2 2025, filed 15 Aug 2025.